Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial

Introduction Low-dose radiation therapy (LDRT) for osteoarthritis (OA) has been performed for several decades. However, supporting evidence from randomised studies using modern methodologies is lacking, and a recently published randomised study failed to show the significant benefit of LDRT. The pre...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyu Sun, Won Park, Dong Hyun Kim, Ji Hyun Lee, Joon Ho Wang, Hak Jae Kim, Kichul Shin, Min Jung Kim, Ji Young Kim, Byoung Hyuck Kim, Du Hyun Ro, Dae-Hee Lee, Eun-Hee Hong, Seong-Jun Cho, Hyuk-Soo Han
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e069691.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849709216868073472
author Jiyu Sun
Won Park
Dong Hyun Kim
Ji Hyun Lee
Joon Ho Wang
Hak Jae Kim
Kichul Shin
Min Jung Kim
Ji Young Kim
Byoung Hyuck Kim
Du Hyun Ro
Dae-Hee Lee
Eun-Hee Hong
Seong-Jun Cho
Hyuk-Soo Han
author_facet Jiyu Sun
Won Park
Dong Hyun Kim
Ji Hyun Lee
Joon Ho Wang
Hak Jae Kim
Kichul Shin
Min Jung Kim
Ji Young Kim
Byoung Hyuck Kim
Du Hyun Ro
Dae-Hee Lee
Eun-Hee Hong
Seong-Jun Cho
Hyuk-Soo Han
author_sort Jiyu Sun
collection DOAJ
description Introduction Low-dose radiation therapy (LDRT) for osteoarthritis (OA) has been performed for several decades. However, supporting evidence from randomised studies using modern methodologies is lacking, and a recently published randomised study failed to show the significant benefit of LDRT. The presented trial aims to evaluate the efficacy and safety of LDRT for patients with knee OA.Methods and analysis This prospective, multicentre, randomised trial will be conducted in the Republic of Korea. A total of 114 participants will be randomly assigned (1:1:1) to receive sham irradiation, 0.3 Gy/6 fractions of LDRT or 3 Gy/6 fractions of LDRT. Key inclusion criteria are primary knee OA with Kellgren-Lawrence grade 2–3 and visual analogue scale 50–90 when walking at the baseline. The primary endpoint is the rate of responders at 4 months after LDRT according to the OARSI-OMERACT criteria. Concomitant use of analgesics is prohibited until the primary efficacy evaluation is scheduled.Ethics and dissemination Currently, approval from the Ministry of Food and Drug Safety of the Republic of Korea and the institutional review board of each participating hospital has been obtained. Patient enrolment began in October 2022 and is ongoing at three participating sites. The results will be disseminated to academic audiences and the public via publication in an international peer-reviewed journal and presentation at conferences. This trial will provide valuable information on the safety and efficacy of LDRT for patients with knee OA.Trial registration number NCT05562271.
format Article
id doaj-art-d7941e4814a849a097e77cbfbbf85027
institution DOAJ
issn 2044-6055
language English
publishDate 2023-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-d7941e4814a849a097e77cbfbbf850272025-08-20T03:15:23ZengBMJ Publishing GroupBMJ Open2044-60552023-02-0113210.1136/bmjopen-2022-069691Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trialJiyu Sun0Won Park1Dong Hyun Kim2Ji Hyun Lee3Joon Ho Wang4Hak Jae Kim5Kichul Shin6Min Jung Kim7Ji Young Kim8Byoung Hyuck Kim9Du Hyun Ro10Dae-Hee Lee11Eun-Hee Hong12Seong-Jun Cho13Hyuk-Soo Han14Medical Research Collaborating Center, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of KoreaInha University Hospital, Incheon, Korea, Rep. of (South Korea)Department of Radiology, Seoul National University Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of KoreaYonsei University College of Medicine, Seoul, South KoreaDepartment of Orthopedic Surgery, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of KoreaDepartment of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of KoreaCollaborator (non-author)Radiation Health Research Institute, Korea Hydro & Nuclear Power Co Ltd, Seoul, Republic of KoreaRadiation Oncology, Seoul National University College of Medicine, Seoul, Republic of KoreaDepartment of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul, Republic of KoreaDepartment of Orthopedic Surgery, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaRadiation Health Research Institute, Korea Hydro & Nuclear Power Co Ltd, Seoul, Republic of KoreaRadiation Health Research Institute, Korea Hydro & Nuclear Power Co Ltd, Seoul, Republic of KoreaDepartment of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul, Republic of KoreaIntroduction Low-dose radiation therapy (LDRT) for osteoarthritis (OA) has been performed for several decades. However, supporting evidence from randomised studies using modern methodologies is lacking, and a recently published randomised study failed to show the significant benefit of LDRT. The presented trial aims to evaluate the efficacy and safety of LDRT for patients with knee OA.Methods and analysis This prospective, multicentre, randomised trial will be conducted in the Republic of Korea. A total of 114 participants will be randomly assigned (1:1:1) to receive sham irradiation, 0.3 Gy/6 fractions of LDRT or 3 Gy/6 fractions of LDRT. Key inclusion criteria are primary knee OA with Kellgren-Lawrence grade 2–3 and visual analogue scale 50–90 when walking at the baseline. The primary endpoint is the rate of responders at 4 months after LDRT according to the OARSI-OMERACT criteria. Concomitant use of analgesics is prohibited until the primary efficacy evaluation is scheduled.Ethics and dissemination Currently, approval from the Ministry of Food and Drug Safety of the Republic of Korea and the institutional review board of each participating hospital has been obtained. Patient enrolment began in October 2022 and is ongoing at three participating sites. The results will be disseminated to academic audiences and the public via publication in an international peer-reviewed journal and presentation at conferences. This trial will provide valuable information on the safety and efficacy of LDRT for patients with knee OA.Trial registration number NCT05562271.https://bmjopen.bmj.com/content/13/2/e069691.full
spellingShingle Jiyu Sun
Won Park
Dong Hyun Kim
Ji Hyun Lee
Joon Ho Wang
Hak Jae Kim
Kichul Shin
Min Jung Kim
Ji Young Kim
Byoung Hyuck Kim
Du Hyun Ro
Dae-Hee Lee
Eun-Hee Hong
Seong-Jun Cho
Hyuk-Soo Han
Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
BMJ Open
title Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
title_full Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
title_fullStr Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
title_full_unstemmed Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
title_short Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial
title_sort low dose radiation therapy for patients with knee osteoarthritis lord knea a protocol for a sham controlled randomised trial
url https://bmjopen.bmj.com/content/13/2/e069691.full
work_keys_str_mv AT jiyusun lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT wonpark lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT donghyunkim lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT jihyunlee lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT joonhowang lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT hakjaekim lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT kichulshin lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT minjungkim lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT jiyoungkim lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT byounghyuckkim lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT duhyunro lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT daeheelee lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT eunheehong lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT seongjuncho lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial
AT hyuksoohan lowdoseradiationtherapyforpatientswithkneeosteoarthritislordkneaaprotocolforashamcontrolledrandomisedtrial